EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

T Zuberbier, R Asero, C Bindslev-Jensen, G Walter Canonica, M K Church, A Giménez-Arnau, C E H Grattan, A Kapp, H F Merk, B Rogala, S Saini, M Sánchez-Borges, P Schmid-Grendelmeier, H Schünemann, P Staubach, G A Vena, B Wedi, M Maurer

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Resumé

Udgivelsesdato: 2009-Oct
OriginalsprogEngelsk
TidsskriftAllergy. European Journal of Allergy and Clinical Immunology
Vol/bind64
Udgave nummer10
Sider (fra-til)1417-26
Antal sider9
ISSN0105-4538
DOI
StatusUdgivet - 1. okt. 2009

Fingeraftryk

Urticaria
Dermatology
Allergy and Immunology
Hypersensitivity
Organizations
Guidelines
Consensus
European Union
Siblings
Quality of Life

Citer dette

Zuberbier, T ; Asero, R ; Bindslev-Jensen, C ; Walter Canonica, G ; Church, M K ; Giménez-Arnau, A ; Grattan, C E H ; Kapp, A ; Merk, H F ; Rogala, B ; Saini, S ; Sánchez-Borges, M ; Schmid-Grendelmeier, P ; Schünemann, H ; Staubach, P ; Vena, G A ; Wedi, B ; Maurer, M. / EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. I: Allergy. European Journal of Allergy and Clinical Immunology. 2009 ; Bind 64, Nr. 10. s. 1417-26.
@article{a32e4300b96f11deab49000ea68e967b,
title = "EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria",
abstract = "This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Gim{\'e}nez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 64:1427-1443] is the result of a consensus reached during a panel discussion at the 3rd International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). Urticaria is a frequent disease. The life-time prevalence for any subtype of urticaria is approximately 20{\%}. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms. In addition, it outlines evidence-based diagnostic approaches for different subtypes of urticaria. The correct management of urticaria, which is of paramount importance for patients, is very complex and is consequently covered in a separate guideline developed during the same consensus meeting. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).",
author = "T Zuberbier and R Asero and C Bindslev-Jensen and {Walter Canonica}, G and Church, {M K} and A Gim{\'e}nez-Arnau and Grattan, {C E H} and A Kapp and Merk, {H F} and B Rogala and S Saini and M S{\'a}nchez-Borges and P Schmid-Grendelmeier and H Sch{\"u}nemann and P Staubach and Vena, {G A} and B Wedi and M Maurer",
year = "2009",
month = "10",
day = "1",
doi = "10.1111/j.1398-9995.2009.02179.x",
language = "English",
volume = "64",
pages = "1417--26",
journal = "Allergy: European Journal of Allergy and Clinical Immunology",
issn = "0105-4538",
publisher = "Wiley Online",
number = "10",

}

Zuberbier, T, Asero, R, Bindslev-Jensen, C, Walter Canonica, G, Church, MK, Giménez-Arnau, A, Grattan, CEH, Kapp, A, Merk, HF, Rogala, B, Saini, S, Sánchez-Borges, M, Schmid-Grendelmeier, P, Schünemann, H, Staubach, P, Vena, GA, Wedi, B & Maurer, M 2009, 'EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria', Allergy. European Journal of Allergy and Clinical Immunology, bind 64, nr. 10, s. 1417-26. https://doi.org/10.1111/j.1398-9995.2009.02179.x

EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. / Zuberbier, T; Asero, R; Bindslev-Jensen, C; Walter Canonica, G; Church, M K; Giménez-Arnau, A; Grattan, C E H; Kapp, A; Merk, H F; Rogala, B; Saini, S; Sánchez-Borges, M; Schmid-Grendelmeier, P; Schünemann, H; Staubach, P; Vena, G A; Wedi, B; Maurer, M.

I: Allergy. European Journal of Allergy and Clinical Immunology, Bind 64, Nr. 10, 01.10.2009, s. 1417-26.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

TY - JOUR

T1 - EAACI/GA(2)LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria

AU - Zuberbier, T

AU - Asero, R

AU - Bindslev-Jensen, C

AU - Walter Canonica, G

AU - Church, M K

AU - Giménez-Arnau, A

AU - Grattan, C E H

AU - Kapp, A

AU - Merk, H F

AU - Rogala, B

AU - Saini, S

AU - Sánchez-Borges, M

AU - Schmid-Grendelmeier, P

AU - Schünemann, H

AU - Staubach, P

AU - Vena, G A

AU - Wedi, B

AU - Maurer, M

PY - 2009/10/1

Y1 - 2009/10/1

N2 - This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 64:1427-1443] is the result of a consensus reached during a panel discussion at the 3rd International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). Urticaria is a frequent disease. The life-time prevalence for any subtype of urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms. In addition, it outlines evidence-based diagnostic approaches for different subtypes of urticaria. The correct management of urticaria, which is of paramount importance for patients, is very complex and is consequently covered in a separate guideline developed during the same consensus meeting. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

AB - This guideline, together with its sister guideline on the management of urticaria [Zuberbier T, Asero R, Bindslev-Jensen C, Canonica GW, Church MK, Giménez-Arnau AM et al. EAACI/GA(2)LEN/EDF/WAO Guideline: Management of urticaria. Allergy, 2009; 64:1427-1443] is the result of a consensus reached during a panel discussion at the 3rd International Consensus Meeting on Urticaria, Urticaria 2008, a joint initiative of the Dermatology Section of the European Academy of Allergology and Clinical Immunology (EAACI), the EU-funded network of excellence, the Global Allergy and Asthma European Network (GA(2)LEN), the European Dermatology Forum (EDF) and the World Allergy Organization (WAO). Urticaria is a frequent disease. The life-time prevalence for any subtype of urticaria is approximately 20%. Chronic spontaneous urticaria and other chronic forms of urticaria do not only cause a decrease in quality of life, but also affect performance at work and school and, as such, are members of the group of severe allergic diseases. This guideline covers the definition and classification of urticaria, taking into account the recent progress in identifying its causes, eliciting factors, and pathomechanisms. In addition, it outlines evidence-based diagnostic approaches for different subtypes of urticaria. The correct management of urticaria, which is of paramount importance for patients, is very complex and is consequently covered in a separate guideline developed during the same consensus meeting. This guideline was acknowledged and accepted by the European Union of Medical Specialists (UEMS).

U2 - 10.1111/j.1398-9995.2009.02179.x

DO - 10.1111/j.1398-9995.2009.02179.x

M3 - Journal article

C2 - 19772512

VL - 64

SP - 1417

EP - 1426

JO - Allergy: European Journal of Allergy and Clinical Immunology

JF - Allergy: European Journal of Allergy and Clinical Immunology

SN - 0105-4538

IS - 10

ER -